James M. Frates, CFO: Amylyx Pharmaceuticals AMLX Sell · Filed 23/03/24

Trade details

Type: Insider sale
Amount: $981,160.56
Shares · price: 30,796 sh · $31.86 a share
Held after: 35,713 sh
Stock: Amylyx Pharmaceuticals AMLX
Person: James M. FratesCFO
Trade date: 23/03/16
Filed: 23/03/24
Days to filing: 8 days

Sold 46.3% of holdings

Share of holding sold: 46.3%

Amylyx Pharmaceuticals trades, last 26 weeks

What else happened in Amylyx Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/02/14~23/04/15

James M. Frates's recent trades

James M. FratesCFO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$349.8K
10,810 sh
$349.8K
Filed 09/11
Traded 09/10
James M. FratesCFO
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$114.8K
7,909 sh
$114.8K
Filed 03/04
Traded 03/02
James M. FratesCFO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$114.9K
7,909 sh
$114.9K
Filed 03/02
Traded 03/02
James M. FratesCFO
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$52.1K
3,557 sh
$52.1K
Filed 02/04
Traded 02/02
James M. FratesCFO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$52.1K
3,557 sh
$52.1K
Filed 02/02
Traded 02/02